Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting Progression to Parkinson's Disease Dementia Using Multivariate Normative Comparisons.

J A Agelink van Rentergem1, N R de Vent1, H M Huizenga1,2,3

  • 1Department of Psychology, University of Amsterdam, Amsterdam, Netherlands.

Journal of the International Neuropsychological Society : JINS
|May 16, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is camouflaging unique for autism? A comparison of camouflaging between adults with autism and ADHD.

Autism research : official journal of the International Society for Autism Research·2024
Same author

Changes in perceived ageism during the COVID-19 pandemic: impact on quality of life and mental well-being among Dutch adults aged 55 and older.

Aging & mental health·2023
Same author

A longitudinal study on cognitive aging in autism.

Psychiatry research·2023
Same author

Time course analyses of orthographic and phonological priming effects in developing readers.

Quarterly journal of experimental psychology (2006)·2017
Same author

Universal Scale of Intelligence Estimates (USIE): Representing Intelligence Estimated From Level of Education.

Assessment·2016
Same author

Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.

Psychological medicine·2016
This summary is machine-generated.

A new multivariate statistical method shows promise in predicting Parkinson's disease dementia (PDD) progression more accurately than traditional criteria for Parkinson's disease with mild cognitive impairment (PD-MCI). This approach offers improved sensitivity and specificity for early detection.

Area of Science:

  • Neuroscience
  • Gerontology
  • Biostatistics

Background:

  • Parkinson's disease with mild cognitive impairment (PD-MCI) is a significant risk factor for developing Parkinson's disease dementia (PDD).
  • Current diagnostic criteria for PD-MCI rely on traditional test-by-test normative comparisons.
  • A more sensitive method for predicting dementia progression is needed.

Purpose of the Study:

  • To evaluate a novel multivariate statistical method for predicting dementia status in PD-MCI patients.
  • To compare the predictive accuracy of this new method against traditional PD-MCI criteria.
  • To assess prediction at 3- and 5-year follow-up intervals.

Main Methods:

  • Analysis of cognitive test results from 123 newly diagnosed PD patients.
Keywords:
ANDIMild cognitive impairmentaggregated databasemultivariate normative comparisonneuropsychological diagnosticsnormative dataregression-based norms

Related Experiment Videos

  • Application of traditional PD-MCI criteria.
  • Application of PD-MCI criteria using an aggregated normative database.
  • Multivariate normative comparisons (MNCs) using the aggregated database.

    • Main Results:

    • The multivariate normative comparisons (MNCs) demonstrated higher sensitivity and specificity in predicting PDD progression.
    • While trends indicated improved classification accuracy, the differences did not reach statistical significance.
    • The study analyzed progression to dementia within 3 and 5 years.

    Conclusions:

    • Multivariate normative comparisons (MNCs) may offer a more accurate prediction of PDD compared to traditional PD-MCI criteria.
    • Encouraging trends in sensitivity and specificity suggest potential for improved early detection.
    • Further validation is warranted to confirm the clinical utility of MNCs in predicting PDD.